Shop All
Parkinson's disease involves progressive dopaminergic neuron loss in the substantia nigra, driven by alpha-synuclein aggregation, mitochondrial dysfunction, neuroinflammation, and gut-brain axis dysregulation. Explore how sea moss fucoidan exhibits neuroprotective properties by inhibiting alpha-synuclein fibrillation and reducing microglial-driven neuroinflammation, how its B vitamins support dopamine cofactor pathways (B6 in DOPA decarboxylase), how manganese and iron balance is critical in Parkinson's pathophysiology, how prebiotic fiber supports the gut-brain axis (gut dysbiosis precedes motor symptoms by years in some patients), and why antioxidant minerals protect surviving dopaminergic neurons from oxidative stress. Critical: sea moss cannot treat Parkinson's disease -- neurologist oversight, levodopa/carbidopa, and disease-modifying research remain the standard of care.
For the complete science-backed breakdown, including mechanisms, dosing, timing, and safety considerations, read our full guide:
Sea Moss for Parkinson's: Dopamine Precursors, Neuroinflammation, and Neuroprotection
Key topics covered:
- The specific compounds in sea moss relevant to this condition
- Mechanistic pathways (not just anecdotal claims)
- Evidence-based dosing protocols and timing
- Drug interactions and contraindications
- How to integrate with conventional medical care
- What results are realistic and on what timeline
